Guidance on minimally important clinical difference and trial size is needed.

Guidance on minimally important clinical difference and trial size is needed.

Bibliographic Details
Main Authors:	Cook, J, Ramsay, C, Vale, L
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Choosing the target difference ('effect size') for a randomised controlled trial - DELTA(2) guidance protocol.
by: Cook, JA, et al.
Published: (2017)

Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance
by: Sones, WR, et al.
Published: (2018)

DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial
by: Cook, J, et al.
Published: (2018)

DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial
by: Cook, J, et al.
Published: (2018)

Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers.
by: Cook, J, et al.
Published: (2015)

DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial
by: Jonathan A. Cook, et al.
Published: (2018-11-01)

Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial – the development of the DELTA2 guidance
by: William Sones, et al.
Published: (2018-10-01)

Minimum important difference is minimally important in sample size calculations
by: Hubert Wong
Published: (2023-01-01)

Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial – the development of the DELTA2 guidance
by: William Sones, et al.
Published: (2019-10-01)

The importance of clinical importance when determining the target difference in sample size calculations
by: Parker, RA, et al.
Published: (2023)

The importance of clinical importance when determining the target difference in sample size calculations
by: Richard A. Parker, et al.
Published: (2023-08-01)

Minimal clinically important difference: The basics
by: Julieta Aldana Salas Apaza, et al.
Published: (2021-04-01)

Use of methods for specifying the target difference in randomised controlled trial sample size calculations: Two surveys of trialists' practice.
by: Cook, J, et al.
Published: (2014)

Minimal Clinically Important Difference of Scales Reported in Stroke Trials: A Review
by: Biswamohan Mishra, et al.
Published: (2024-01-01)

New guidance to improve sample size calculations for trials: eliciting the target difference
by: Melanie L. Bell
Published: (2018-11-01)

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
by: Christopher H. Van Dyck, et al.
Published: (2023-04-01)

What is a minimal clinically important difference?
by: Harkness Michael
Published: (2023-12-01)

Need of minimal important difference for oral health-related quality of life measures
by: Masood, M., et al.
Published: (2012)

Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
by: Eva M. Gamper, et al.
Published: (2021-10-01)

Recruitment to publicly funded trials--are surgical trials really different?
by: Cook, J, et al.
Published: (2008)

Minimal clinically important difference in idiopathic pulmonary fibrosis
by: Mohleen Kang, et al.
Published: (2021-06-01)

What is a minimal clinically important difference for clinical trials in patients with disorders of consciousness? a novel probabilistic approach
by: Martin M. Monti, et al.
Published: (2023-01-01)

What is a minimal clinically important difference for clinical trials in patients with disorders of consciousness? a novel probabilistic approach.
by: Martin M Monti, et al.
Published: (2023-01-01)

Resilience Profile of Children with Special Needs and the Importance of Guidance and Counseling Services
by: Novida Nurhayati, et al.
Published: (2023-12-01)

Minimal Clinically Important Differences for a Weight Distribution Platform in Dogs with Osteoarthritis
by: J. C. Alves, et al.
Published: (2023-12-01)

Rapid guidelines – timely and important guidance needed for setting standards and best practices
by: Tikki Pang, et al.
Published: (2018-06-01)

Use of the minimal important difference as a criterion for clinical importance—are we off track?
by: Stefan Moosmayer, MD, PhD
Published: (2023-02-01)

Minimal Clinically Important Difference in Barthel Index Dyspnea in Patients with COPD
by: Vitacca M, et al.
Published: (2020-10-01)

Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is needed
by: Shaun Treweek, et al.
Published: (2020-01-01)

Demystifying the Value of Minimal Clinically Important Difference in the Cardiothoracic Surgery Context
by: Dimitrios E. Magouliotis, et al.
Published: (2023-03-01)

Sensitivity to change and minimal clinically important difference of the angioedema control test
by: Lauré M. Fijen, et al.
Published: (2023-09-01)

Minimal clinically important difference for asthma endpoints: an expert consensus report
by: Matteo Bonini, et al.
Published: (2020-06-01)

The Importance and Vital Need of a Spiritual Guidance to the Orthodox Christian on the Way to the Kingdom of Heaven
by: priest Andrij Hromiak
Published: (2016-10-01)

Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD
by: Rebelo P, et al.
Published: (2020-01-01)

Guidance on interim analysis methods in clinical trials
by: Jody D. Ciolino, et al.
Published: (2023-01-01)

Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.
by: Hislop, J, et al.
Published: (2014)

Dermatomyositis: Practical Guidance and Unmet Needs
by: Cassard L, et al.
Published: (2024-03-01)

Data sharing in clinical trials – practical guidance on anonymising trial datasets
by: Catriona Keerie, et al.
Published: (2018-01-01)

Estimating Minimal Clinically Important Differences for Knee Range of Motion after Stroke
by: Agnieszka Guzik, et al.
Published: (2020-10-01)

Determining Minimal Clinically Important Differences in Japanese Cedar/Cypress Pollinosis Patients
by: Takaya Higaki, et al.
Published: (2013-01-01)